Kobayashi Pharmaceutical (4967.T)

Overall impact
B (75)

Commentary

Kobayashi Pharmaceutical is a strong overall performer. With a 'B' rating of 74.8 for overall impact (89th percentile compared to all companies), Kobayashi Pharmaceutical ranks 8th out of 64 industry peers, behind Jerash, Essity, Mannatech and 4 others, and ahead of Energizer, Lifevantage, Dogness and 53 others. On top material causes for Kobayashi Pharmaceutical's industry (Consumer Discretionary Products), Kobayashi Pharmaceutical performs well in Reduced Green House Gas Emissions (89.9 score), Quality Primary Education (83.5), Disaster Readiness and Effective Aid (92.4) and 7 other causes where it received an 'A' score and performs poorly in Child and Maternal Health (37.5 score).
Impact
Cause 4967.T
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company

Kobayashi Pharmaceutical

Employees
3,731
Sector
Consumer Staples
Industry
Household Products
Sub-industry
Household Products
SASB industry
Household & Personal Products
Headquarters
Japan
Share classes
4967.T
Description
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese medicine; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air freshener, lens cleaner, cooling gel sheets, and oral hygiene products. It also manufactures and sells pharmaceuticals, cosmetics, and health foods; and manufactures and sells synthetic resin products; markets nutritional supplements and skin care products through mail orders; and sells skincare products, daily necessities, and health foods, as well as manufactures body warmers. In addition, the company engages in transportation, real estate management, and advertising planning and production businesses; manufacture of sanitary and paper products; and asset management. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
Material causes
Ethos considers the following causes material for Kobayashi Pharmaceutical, based on its industry sub-industry Household Products. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.